Study evaluating safety, tolerability, PK/PD of surovatamig in adult RA or SLE participants

Trial Identifier:	D740AC00001
Sponsor:	AstraZeneca
Start Date:	November 2025
Primary Completion Date:	June 2028
Study Completion Date:	June 2028
Condition:	Rheumatoid Arthritis; Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.